The increased production of TMAO has been linked to various health conditions, like cardiovascular diseases, atherosclerosis and stroke as mentioned above [24]
Eli Lilly has not confirmed an exact date
While the shortage of 1 mg Ozempic pens was resolved in Canada in early January, Novo Nordisk is expecting a shortage of its 0.25/0.5 mg pens until March
doi: 10.1111/j.1572-0241.2005.00354.x
It outlines the peptides potential benefits, including reducing inflammation, repairing the gut lining, improving blood flow, and supporting the guts nerve network
However, several clinical considerations may influence selection: Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use any GLP-1 receptor agonist